Global Hemodialysis Market to Grow at a CAGR of 5.51% During 2024-2032, Driven by Advancements in Dialysis Technology

The hemodialysis market size is likely to increase by the growing prevalence of end-stage renal disease (ESRD) worldwide, along with an increasing geriatric population base susceptible to kidney disorder. The growing number of patients suffering from diabetes and hypertension are more susceptible to develop kidney diseases. Additionally, advancements in dialysis technology and increasing awareness about renal health and treatment options are driving market growth.

The market report examines a range of factors fuelling market growth, assessing both the opportunities and challenges affecting the market. Additionally, it delivers insights into the competitive dynamics, equipping market leaders with valuable information.

In September 2023 , Quanta Dialysis Technologies submitted a 510(k) premarket notification to the FDA for expanding the indication of its Quanta Dialysis System for self-care, in-home hemodialysis. This submission, if cleared by the FDA, would make the Quanta Dialysis System the third device in the United States indicated for home hemodialysis (HHD) in patients with end-stage kidney disease (ESKD).

The system is currently used in chronic and acute care settings. The expansion to include in-home use aims to provide patients with more control over their care, offering freedom and flexibility compared to traditional in-center dialysis. The FDA clearance for the expanded indication is expected in 2024. Quanta's submission is supported by clinical data from its Home Run™ study, demonstrating the efficacy and safety of the system for HHD.

Diality Inc.,  a medical technology company, is set to unveil its Moda-flx Hemodialysis System™ at ASN Kidney Week 2023, showcasing a platform designed for flexibility, ease of use, and mobility in dialysis care. The technology will be featured in a poster session titled “Blood Flowrate Accuracy with Diality Hemodialysis System” [SA-P0618] on Saturday, November 4.

Moda-flx aims to empower healthcare professionals to choose the right hemodialysis prescription, water/dialysate-generation option, and an easy-to-learn interface suitable for specialists and non-nephrology clinicians. Diality's CEO, Osman Khawar, stated that the system reflects its mission to improve lives impacted by kidney disease.

The hemodialysis market demand is influenced by a complex interplay of factors that reflect the changing landscape of healthcare needs, technological progress, and socio-economic trends. At the forefront is the escalating prevalence of chronic kidney disease (CKD) and End-Stage Renal Disease (ESRD), driven by an increase in diabetes, hypertension, obesity, and an aging population, necessitating the need for renal replacement therapies such as hemodialysis.

The aging demographic particularly underscores this demand, as older individuals are more susceptible to chronic conditions that may lead to kidney failure. Technological advancements in dialysis treatments have also played a significant role, making hemodialysis more efficient, patient-friendly, and accessible, thus broadening its acceptance and preference among patients.

Government policies and healthcare infrastructure development, especially in emerging economies, have been pivotal in making hemodialysis services more widely available and affordable, further stimulating market demand. Additionally, the global rise in healthcare expenditure facilitates the expansion of dialysis centers and the adoption of advanced treatment technologies.

Patient preference for treatments that offer a better quality of life, such as home hemodialysis (HHD), is reshaping market dynamics, emphasizing the need for more flexible and convenient treatment options. The expansion of health insurance coverage plays a critical role in making hemodialysis accessible to a broader population, thereby influencing the overall demand in the global market. These factors collectively shape the hemodialysis market, highlighting the opportunities for growth and the need for continuous innovation to meet the evolving demands.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product and Services, Type, Site, End Users, and Region

• By product and services, the market includes equipment such as dialysis machines, catheters, and others, along with consumables like dialyzers, bloodlines, concentrates, catheters, and services.

• The market segmentation by type comprises conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis, providing diverse treatment options for renal patients.

• Based on site, the hemodialysis market segmentation includes in-center dialysis and home dialysis, offering patients the flexibility to receive treatment either in a clinical setting or in the comfort of their homes.

• End users of the market are hospitals, clinics, home care settings, and others, catering to diverse healthcare environments and patient needs for renal care.

• Geographically, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report

• The report identifies a significant increase in the prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) globally as primary drivers for the hemodialysis market growth. This trend is further supported by the aging population, which is more susceptible to such conditions, and improvements in healthcare infrastructure across various regions, facilitating access to hemodialysis services.

• Hemodialysis market analysis signifies that the role of technological advancements in shaping the hemodialysis market. Innovations in dialysis machines, such as high-efficiency and high-flux membranes, have improved treatment outcomes. These advancements not only enhance the efficiency of hemodialysis procedures but also improve patient comfort and safety, thereby contributing to market growth.

• The report provides detailed insights into market segmentation, including types of hemodialysis (conventional, short daily, and nocturnal), products (machines, consumables, and services), and end-users (hospitals, clinics, and home care settings). This segmentation analysis reveals a growing demand for home hemodialysis services due to their convenience and the desire for a more comfortable treatment environment, indicating a shift in market dynamics.

• Geographically, the report highlights significant differences in market growth rates, with the Asia-Pacific region showing the highest growth potential. This is attributed to the large patient pool, increasing healthcare expenditure, and the expanding healthcare infrastructure in countries such as China and India. Moreover, the report notes the mature markets of North America and Europe, where growth is driven by technological advancements and strong healthcare systems.

• The report addresses the challenges facing the hemodialysis market, including the high cost of hemodialysis treatment and associated complications, which may hinder market growth. However, it also identifies opportunities in the form of increasing investments in research and development to improve dialysis techniques and reduce treatment costs. Additionally, the rising awareness and government initiatives in emerging economies present significant growth opportunities for the hemodialysis market.

Key Offerings of the Report 

• The EMR report gives an overview of the global hemodialysis market for the periods (2017-2023) and (2024-2032).

• The report also offers the historical (2017-2023) and forecast (2024-2032) market insights for the product and services, type, site, end users, and region.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global hemodialysis market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., DaVita Inc., Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co., Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Toray Industries, Inc., Allmed Medical Corporation, MEDIVATORS Inc., Rockwell Medical, Inc., Medtronic plc, Teleflex Incorporated, and JMS Co., Ltd.

Key Highlights of the Report

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.